Format

Send to

Choose Destination
See comment in PubMed Commons below
Rev Neurol (Paris). 2011 Feb;167(2):160-3. doi: 10.1016/j.neurol.2010.06.003. Epub 2010 Jul 31.

[Diagnosis contribution of biomarkers in Alzheimer disease: A case of frontotemporal dementia].

[Article in French]

Author information

1
Unité de neuropsychologie-CM2R, CHU de Sainte-Étienne-hôpital Nord, avenue Albert-Raymond, 42055 Saint-Étienne cedex 02, France. aurel.richard@gmail.com

Abstract

INTRODUCTION:

Cerebrospinal fluid biomarkers are a fundamental contribution for the diagnosis of Alzheimer disease, in particular for young people.

CASE REPORT:

We report a case of Alzheimer disease of a 51-years old man whose clinical presentation corresponded to frontotemporal behavioural criteria. The clinical evaluation noticed some troubles in verbal memory. Only the CSF biomarkers confirmed the diagnosis.

CONCLUSION:

There are different phenotypes of presenile Alzheimer disease and among them we note frontotemporal dementia. It is very important to identify them to introduce a specific treatment.

PMID:
20673934
DOI:
10.1016/j.neurol.2010.06.003
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Masson (France)
    Loading ...
    Support Center